chr3-186853097-GC-G
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 2 ACMG points: 2P and 0B. PM2
The NM_004797.4(ADIPOQ):c.42del(p.Gly15ValfsTer154) variant causes a frameshift change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000137 in 1,461,884 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: not found (cov: 33)
Exomes 𝑓: 0.0000014 ( 0 hom. )
Consequence
ADIPOQ
NM_004797.4 frameshift
NM_004797.4 frameshift
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 0.456
Genes affected
ADIPOQ (HGNC:13633): (adiponectin, C1Q and collagen domain containing) This gene is expressed in adipose tissue exclusively. It encodes a protein with similarity to collagens X and VIII and complement factor C1q. The encoded protein circulates in the plasma and is involved with metabolic and hormonal processes. Mutations in this gene are associated with adiponectin deficiency. Multiple alternatively spliced variants, encoding the same protein, have been identified. [provided by RefSeq, Apr 2010]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 2 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
ADIPOQ | NM_004797.4 | c.42del | p.Gly15ValfsTer154 | frameshift_variant | 2/3 | ENST00000320741.7 | |
ADIPOQ-AS1 | NR_046662.2 | n.2360del | non_coding_transcript_exon_variant | 4/4 | |||
ADIPOQ | NM_001177800.2 | c.42del | p.Gly15ValfsTer154 | frameshift_variant | 3/4 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
ADIPOQ | ENST00000320741.7 | c.42del | p.Gly15ValfsTer154 | frameshift_variant | 2/3 | 1 | NM_004797.4 | P1 | |
ADIPOQ | ENST00000444204.2 | c.42del | p.Gly15ValfsTer154 | frameshift_variant | 3/4 | 1 | P1 | ||
ADIPOQ-AS1 | ENST00000422718.1 | n.2231del | non_coding_transcript_exon_variant | 3/3 | 5 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD3 genomes
Cov.:
33
GnomAD4 exome AF: 0.00000137 AC: 2AN: 1461884Hom.: 0 Cov.: 31 AF XY: 0.00000138 AC XY: 1AN XY: 727244
GnomAD4 exome
AF:
AC:
2
AN:
1461884
Hom.:
Cov.:
31
AF XY:
AC XY:
1
AN XY:
727244
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome Cov.: 33
GnomAD4 genome
Cov.:
33
Bravo
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | Oct 06, 2017 | The c.42delC variant in the ADIPOQ gene has not been reported previously as a pathogenic variant nor as a benign variant, to our knowledge. The c.42delC variant causes a frameshift starting with codon Glycine 15, changes this amino acid to a Valine residue, and creates a premature Stop codon at position 154 of the new reading frame, denoted p.Gly15ValfsX154. This variant is predicted to cause loss of normal protein function through protein truncation. The c.42delC variant is not observed in large population cohorts (Lek et al., 2016). We interpret c.42delC as a variant of uncertain significance. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at